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Abstract
Greece, a malaria-free country since 1974, has experienced re-emergence of Plasmodium
vivax autochthonous malaria cases in some agriculture areas over the last three years. In
early 2012, an integrated control programme (MALWEST Project) was launched in order to
prevent re-establishment of the disease. In the context of this project, the rapid diagnostic
tests (RDT) of SD Bioline Malaria Ag Pf/Pan that detects hrp-2 and pan-LDH antigens were
used. The aim of this study was to assess the field application of the RDT for the P. vivax di-
agnosis in comparison to light microscopy and polymerase chain reaction (PCR). A total of
955 samples were tested with all three diagnostic tools. Agreement of RDT against micros-
copy and PCR for the diagnosis of P. vivax was satisfactory (K value: 0.849 and 0.976, re-
spectively). The sensitivity, specificity and positive predictive value of RDT against PCR
was 95.6% (95% C.I.: 84.8-99.3), 100% (95% C.I.: 99.6-100.0) and 100% (95% CI: 91.7-
100.0) respectively, while the sensitivity, specificity and positive predictive value of RDT
against microscopic examination was 97.4% (95% C.I.: 86.1-99.6), 99.4% (95% C.I.: 98.6-
99.8) and 86.1% (95% CI: 72.1-94.7), respectively. Our results indicate that RDT performed
satisfactory in a non-endemic country and therefore is recommended for malaria diagnosis,
especially in areas where health professionals lack experience on light microscopy.
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Introduction
Malaria remains the most important parasitic disease as over one hundred countries worldwide
are endemic [1]; the World Health Organization (WHO) estimates that malaria caused 197
million cases and 584 thousand deaths during 2013 [2]. Greece has been malaria-free since
1974 [3,4]. Until 1999, a number of imported cases have been reported each year and only spo-
radic autochthonous cases during the following decade [5]. During the 2011 and 2012 trans-
mission seasons (May to November), outbreaks took place in an agricultural area (Evrotas
municipality, Lakonia regional unit, South Greece), while sporadic locally acquired cases were
recorded throughout the country. Forty two autochthonous cases were reported in 2011 and 20
autochthonous malaria vivax cases were recorded in 2012 [6]. The estimated incidence of ma-
laria cases in Greece was extremely low in specific agricultural areas of the country where im-
migrants from endemic countries lived and worked. In particular, the cumulative incidence of
autochthonous malaria cases in Evrotas municipality was 0.26% from 2011 to 2012. For the
same period, the cumulative incidence of autochthonous malaria cases in other areas (e.g. Mar-
athon municipality in East Attica region unit) was even lower than Evrotas and was estimated
at 0.009%.
In January 2012, an “Integrated surveillance and control programme for West Nile virus
and malaria in Greece” (MALWEST Project) was launched. Regarding malaria, the following
actions were implemented: a) focus investigation in all autochthonous cases, b) an active case
detection programme in areas with autochthonous cases, c) a mass screening program in im-
migrant and native populations in the Evrotas municipality and at points of entry. The main
goal was to detect and treat malaria cases or carriers of the malaria parasite.
SD Bioline Malaria Ag Pf/Pan Rapid Diagnostic Test (RDT) that detects hrp-2 and pan-
LDH antigens was introduced in the above interventions for malaria diagnosis, while laborato-
ry confirmation of suspected malaria cases was obtained by the examination of blood specimen
sent to the National Malarial Reference Center (National School of Public Health, NMRC).
RDT is a lateral flow test that can detect malaria antigens in a small amount of blood (5 μL)
and is based on the immunochromatographic principles—capture of parasite antigen using
monoclonal antibodies against a malaria antigen [7]. It is estimated that over 200 different
RDTs are commercially available [8], while a number of over 74 million RDTs were distributed
during 2011, 72% of them in Africa, 22% in Southeast Asia and 4% in Eastern Mediterranean
[9]. However, information is limited in regards to the evaluation of the use and performance of
RDTs in non-endemic areas [8]. As Greece had been malaria-free for over 35 years, current ex-
perience on light microscopy regarding malaria diagnosis is quite low. Therefore, the effective-
ness of RDT was assessed in order to find out whether this diagnostic tool could be routinely
used for the diagnosis of malaria in a non-endemic country.
Conventional microscopic examination of both thick and thin Giemsa stained blood smears
has been widely accepted as the examination of choice for malaria diagnosis [10,11,12], but
since the quality of microscopy-based diagnosis is frequently compromised [13], PCR seems to
have been gaining ground in accurate malaria diagnosis [14]. Thus, this study compares the
field application of the RDT for malaria diagnosis against light microscopy and PCR.
Materials and Methods
Study population—Sample collection
Our study population included immigrants and Greek population tested for malaria with
RTDs, microscopy and PCR during active case detection (visits for fever/symptoms screening
every 15 days in immigrants’ quarters), focus investigation (investigation of all residents
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around the case’s house in a distance of 100 m) and mass screening activities that took place in
regions where autochthonous cases of malaria occurred: Evrotas municipality (Lakonia region-
al unit, South Greece), where the outbreak took place, Marathon municipality (East Attica re-
gional unit), Thebes municipality (Viotia regional unit, Central Greece) and Sofades
municipality (Karditsa regional unit, Central Greece). RDT was performed by field health pro-
fessionals on site. The health professionals were all medical doctors who received theoretical
and practical training on RDTs organized by NMRC.
The blood samples were placed in EDTA tubes and transferred to the Peripheral Health
Centres where the slides for light microscopy were prepared and tested. The slides were pre-
pared and read by microbiologists who received detailed theoretical and practical training or-
ganized by NMRC and their performance was monitored by participation in external quality
control scheme. The NMRC also participated successfully in external quality control scheme.
Then both slides and EDTA tubes were transferred to the NMRC in iceboxes (0–5°C) within
<6 hours for confirmation and PCR.
Diagnostic tools
The diagnostic tools used were RDT, PCR and light microscopy (peripheral blood smears).
RDT. The SD Bioline Malaria Ag P.f./Pan 05FK60 rapid test was used in our study. The
test was performed and the results interpreted according to manufacturer’s instructions.
In case the control line did not appear, the test was considered as invalid and it was repeated
immediately. Test kits were stored at a dry place (25–28°C).
PCR. The first stage was the DNA extraction from 400 μL of fresh blood that was per-
formed using either the Purelink Genomic DNAmini kit or the iPrep Purelink gDNA Blood
kit with the iPrep Purification Instrument (Invitrogen, Carlsbad, CA) in a final extraction vol-
ume of 100 μL. PCR for malaria detection and discrimination between P. falciparum and P.
vivax was performed using primers PL3, PL4 and PL5 [15] in a final reaction volume of 30 μL
into which 3 μL of the extracted DNA was added. Amplification products were run on a 2%
agarose gel and samples producing the 266 bp band were considered positive for P.vivax. Un-
like other two-step procedures that are time-consuming and labor intensive, the present PCR is
a single-step method (which is a very useful feature for routine laboratory practice) and also
with very satisfactory detection levels [15].
Light microscopy. The smears were prepared from EDTA anticoagulated venous blood.
To prepare the thick smear, a blood drop was put on the one edge of the slide and then spread
in a circle with the use of another’s slide sharp corner. It was then dried for about half an hour
and it was not fixed with menthanol. In this way, red blood cells were hemolyzed and thus the
microscopist could see leucocytes and malaria parasites on the smear recognizing specific
forms of parasite life cycle (e.g. trophozoites, gametocytes, schizonts) [16]. At least one hun-
dred (100) good fields of a thick smear were carefully examined for about 10 minutes. After
that a slide could be declared negative. If parasites were seen, further 100 fields were examined
to identify a potential mixed infection. To prepare a thin film, a blood drop was spread on a
slide and then dried for about 10 minutes and fixed in menthanol. In this case, at least four
hundred (400) fields of a thin slide were examined for about 30 minutes. Species confirmation
and parasite densities were obtained by examining the thin film. The result was expressed in a
percentage of Red Blood Cells (RBC) parasites.
Ethics approval
The field application of SD Bioline Malaria Ag Pf/Pan RDT in Greece was approved by the
Committee for Vector Borne Diseases in the Hellenic Centre for Disease Control and
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Prevention (HCDCP) and by the Review Board of the Greek Ministry of Health. Written con-
sent statement was completed by all participants. In case of children participated in the study,
the written consent statement was signed by parents or guardians. Moreover, mediators/trans-
lators participated in all activities related to immigrants and supported the process of signing
the written consent statements, which were translated in four languages.
Statistical analysis
Results data on the three diagnostic tests for malaria (PCR, light microscopy and RDT) were
entered in a predesigned specific database. SPSS version 17.0 software was used for the statisti-
cal analysis of the data. Sensitivity, specificity, PPV, negative predictive value (NPV) and posi-
tive and negative likelihood ratio (LR) were calculated for the above mentioned tests along
with their 95% confidence intervals (95% C.I.). In order to be able to calculate the positive like-
lihood ratio, the value of 100% of specificity was replaced with 99.5%. The level of agreement
between various diagnostic tests was assessed through the calculation of Kappa value.
Results
The total number of samples obtained during 2012 through the coordinate actions of MAL-
WEST project and HCDCP is presented in Fig. 1. The analysis was restricted in those samples
that were tested with all three diagnostic tools (PCR, light microscopy and RDT). In particular,
out of 959 samples that were examined with all three diagnostic tools, four samples were
Fig 1. Flow chart of all samples collected for malaria in Greece (2012).
doi:10.1371/journal.pone.0120367.g001
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positive for P. falciparum (all imported cases) in both microscopy and PCR and thus they were
not included in the analysis (total number of 955).
As shown in Table 1, out of 955 samples included in the analysis, 46 were Greeks and 909
immigrants, the majority of whom from malaria endemic countries (e.g. Pakistan, Afghani-
stan). Sixteen of the immigrants were from Romania and Morocco (non-endemic countries);
however, the immigrants from both endemic and non-endemic countries stayed in the same
quarters in the agricultural regions where autochthonous cases occurred. The arrival date was
recorded in only 635 out of 909 immigrants (mean duration of stay in Greece: 33.9 months) be-
cause most of the immigrants were undocumented and the information collected was self-re-
ported. Of the 955 cases, 93 (9.7%) were tested with the three diagnostic tools in the context of
symptoms compatible with malaria (including fever). These individuals were identified either
through active case detection or through the Peripheral Health Centers or hospitals in the re-
gions where autochthonous cases occurred. The remaining 862 samples were tested within the
focus investigation and the mass screening activities. In particular, 210 (21.9%) were tested
within the focus investigation and 652 (68.4%) within the mass screening activities.
Out of 45 PCR positive samples, 11 were Greeks and 34 immigrants. The main demographic
data of these samples are given in Table 1. Out of 45 positive PCR malaria cases, 19 had symp-
toms compatible with malaria (including fever) and only 21 of them (46.7%) were hospitalized.
The most common symptoms were headache (46.7%), fever>38°C (42.2%), myalgia and ar-
thralgia (31.1%), vomiting or nausea (20%) and chills (17.7%), whereas anemia was recorded
in 24.4%. According to the HCDCP guidelines, a combination of chloroquine for two days and
primaquine for 14 days was the antimalarial regimen used to treat all 45 malaria cases.
Table 2 illustrates the results of RDT for P. vivax in comparison to PCR as the reference di-
agnostic method. The sensitivity and specificity of RDT against PCR was 95.6% (95% C.I.:
84.8–99.3) and 100% (95% C.I.: 99.6–100.0), respectively. The PPV was 100% (95% C.I.: 91.7–
Table 1. Description of samples included in the analysis.
Number of samples Data for study
population
Immigrants Greek population
955 included in the
analysis
Samples distribution 909 46
Mean age Mean age: 26.7 years old (range: 3–67) Mean age: 27.0 years
old (range: 1–91)
Country of origin Pakistan: 830/909 (91.3%), Afghanistan: 37/909 (4.1%), Bangladesh:
15/909 (1.7%), India: 11/909 (1.2%), Romania: 10/909 (1.0%),
Morocco: 6/909 (0.7%)
Greece
Duration of stay in
Greece
Recorded for 635/909, mean duration of stay: 33.9 months (range:
1–264 months)
N/A
93 samples tested in
context of symptoms
(fever)
Samples distribution 75 18
Mean age Mean age: 26.5 years old (range: 10–49) Mean age: 49.2 years
old (range: 2.5–91)
Country of origin Pakistan: 68/75 (90.7%), Afghanistan: 4/75 (5.4%), Bangladesh: 1/75
(1.3%), Romania: 1/75 (1.3%), Morocco: 1/75 (1.3%)
Greece
Duration of stay in
Greece
Recorded for 36/75, mean duration of stay: 33.4 months (range: 3.5–
60 months)
N/A
45 PCR positive samples Samples distribution 34 11
Mean age (45 PCR
positive samples)
Mean age: 23.8 years old (range: 10–49) Mean age: 50.5 years
old (range: 23–82)
Country of origin Pakistan: 21/34 (61.8%), Afghanistan: 9/34 (26.5%), Bangladesh: 2/34
(5.9%), Romania: 1/34 (2.9%), Morocco: 1/34 (2.9%)
Greece
Duration of stay in
Greece
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100.0), while the NPV was 99.8% (95% C.I.: 99.2–100.0). The positive likelihood ratio (LR+)
was 191.1, while the negative likelihood ratio (LR-) was 0.044. Kappa (K) value was 0.976 (95%
C.I.: 0.943–1.000). Out of two samples that were RDT negative and PCR positive, one was
found positive and one negative when examined with light microscopy. The RDT negative and
light microscopy positive was taken from a lady of Greek origin with mild symptoms compati-
ble with malaria, while the RDT negative and the light microscopy negative was obtained from
an immigrant from malaria endemic country who had a severe clinical picture (high fever, my-
algia, headache, symptoms from the respiratory and the gastrointestinal system).
In Table 3, the results of light microscopy in comparison to PCR are presented. The sensitiv-
ity and specificity of microscopy against PCR was 84.4% (95% C.I.: 70.5–93.5) and 100% (95%
C.I.: 99.6–100.0), respectively. The PPV was 100% (95% C.I.: 90.7–100.0), while the NPV was
99.2% (95% C.I.: 98.4–99.7). The LR+ was 168.9, while the LR- was 0.156. K value was 0.912
(95% C.I.: 0.847–0.977). Out of the seven samples that were found to be PCR positive but mi-
croscopy negative, six were RDT positive, while the seventh one was also negative when tested
with the RDT.
Table 4 depicts the results of RDT for Plasmodium vivax in comparison to light microscopy.
The sensitivity and specificity of RDT against microscopic examination was 97.3% (95% C.I.:
86.1–99.6) and 99.4% (95% C.I.: 98.6–99.8) respectively. The PPV was 86.1% (95% C.I.: 72.1–
94.7), while the NPV was 99.9% (95% C.I.: 99.4–100.0). The LR+ was 148.8, while the LR- was
0.027. K value was 0.910 (95% C.I.: 0.843–0.976). It is worth mentioning that the sample which
was RDT negative and microscopy positive was further confirmed by a positive PCR result.
The level of parasitemia in the sample tested RDT negative and light microscopy positive was
Table 2. RDT and PCR results of samples for P. vivax.
PCR
Positive Negative Total
RDT Positive 43 0 43
Negative 2 910 912
Total 45 910 955
doi:10.1371/journal.pone.0120367.t002
Table 3. Microscopy and PCR results of samples for P. vivax.
PCR
Positive Negative Total
Microscopy Positive 38 0 38
Negative 7 910 917
Total 45 910 955
doi:10.1371/journal.pone.0120367.t003
Table 4. RDT andmicroscopy results for P. vivax.
Microscopy
Positive Negative Total
RDT Positive 37 6 43
Negative 1 911 912
Total 38 917 955
doi:10.1371/journal.pone.0120367.t004
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estimated at 0.04%. In addition, the six samples that were RDT positive but microscopy nega-
tive were found also positive with PCR.
Moreover, analysis was conducted to compare the performance of RDT against PCR as the
reference diagnostic method in 93 symptomatic individuals and 862 samples collected during
focus investigation and mass screening activities. Regarding 93 symptomatic individuals, the
sensitivity and specificity of RDT against PCR was 94.7% (95% C.I.: 71.9–99.7) and 100% (95%
C.I.: 93.9–100.0). The PPV was 100% (95% C.I.: 78.1–100.0), while the NPV was 98.7 (95% C.
I.: 91.8–99.9). The LR+ was 189.5, while the LR- was 0.052. K value was 0.966 (95% C.I.: 0.901–
1.000). Regarding the remaining 862 samples, the sensitivity and specificity of RDT against
PCR was 96.2% (95% C.I.: 78.4–99.8) and 100% (95% C.I.: 99.4–100.0). The PPV was 100%
(95% C.I.: 83.4–100.0), while the NPV was 99.9% (95% C.I.: 99.2–100.0). The LR+ was 193.5,
while the LR- was 0.039. K value was 0.979 (95% C.I.: 0.940–1.000).
Discussion
Our results suggest that RDTs demonstrated high sensitivity, specificity, and positive predictive
value for the diagnosis of P. vivaxmalaria in a non-endemic country. The sensitivity of the
used RDT test against PCR and microscopy was 95.6% and 97.4%, respectively, while the speci-
ficity was 100% and 99.4%, respectively, accompanied by high PPV especially when comparing
RDT performance to the gold standard PCR. The RDT seemed to have similar performance
both in symptomatic individuals and individuals participated in focus investigation and mass
screening. In addition, the largest agreement among diagnostic tools was the one between RDT
and PCR, indicating the good performance of RDT even when used in non-endemic country.
Previous studies usually followed a comparison of RDT performance to microscopic and/or
PCR results. In Belgium, which is a non-endemic country, the evaluation of SD Bioline Malaria
Ag Pf/Pan revealed a sensitivity of 92.9% [17]. On the other hand, a number of surveys regard-
ing the evaluation of SD Bioline Malaria Ag Pf/Pan test against microscopy took place in en-
demic countries (Colombia, Korea, Myanmar). In Colombia, sensitivity, specificity, PPV and
NPV for SD Bioline Pf/Pv test were estimated at 92%, 98.7%, 94.5% and 98.1%, respectively
[18]. In Korea, sensitivity of RDT for P. vivax was ranged from 86.8% to 92.7% [19,20], while
in Myanmar, sensitivity, specificity, PPV and NPV for P. vivax/malariae was estimated at
79.4%, 98.5%, 98.7%, 96.3% and 91.6%, respectively [21].
In our study, there were two false negative RDTs, while PCR was positive. One of these
cases had severe symptoms and the possible cause of false negative in both RDT and light mi-
croscopy was that blood sample was taken beyond the period of fever paroxysms. This explana-
tion could be the most acceptable scenario, as two days later all three diagnostic tools were
used in a new blood sample came up positive. The second case was a Greek lady with mild
symptoms who had negative RDT and positive light microscopy and PCR. It should be noted
that, according to our NMRC, the level of parasitemia was extremely low (0.04%) and beyond
the detection limit of RDT (~2000 parasites/μL).
Currently, the WHO recommends confirmation of a malaria suspected case before treatment
starts, either by RDT or by microscopic examination. The choice of the diagnostic tool depends
on the circumstances met in each setting; it has mostly to do with technical skills and epidemio-
logical facts. The presence of high or low prevalence of the disease is related to the PPV of the di-
agnostic tool, while it is already mentioned how the lack of expertise is directly connected to the
conventional light microscopy efficiency. Additionally, when high-skilled light microscopy is
not available, quality-assured RDT are considered acceptable for malaria diagnosis [22,23].
Light microscopy can be sensitive and specific diagnostic tool [24] when used by a well-
trained microscopist, giving the advantages of mixed infections identification, parasitemia level
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determination, treatment success monitoring, requiring little laboratory equipment [12]. How-
ever, false positive results may occur due to wrong smear preparation (artifacts that may be
considered as parasites) or normal blood components that may confuse the microscopist, while
false negative results may appear due to small number of examined fields [7]. Microscopic ex-
amination may not be able to detect low parasitemias and is a method whose value and effec-
tiveness is highly based on the competency of the microscopist [12]; in a non-endemic country
it seems quite reasonable that the microscopists, if not working in parasitological departments
or reference centers or not having had experience from an endemic region, are not familiar with
malaria microscopy features. Although training courses (e-learning and face-to-face) for micro-
biologists and laboratory technicians by malaria experts of the NMRC were organized in the
context of the MALWEST project it was not expected that all malaria cases could be easily diag-
nosed and especially those occurring in semi-immuned immigrants. Thus, it is rather expected
for a non-malaria setting to display weaknesses in microscopic diagnosis of the disease [25].
Molecular testing with PCR seems to have the highest levels of sensitivity, detecting even
one parasite per μL of blood [15] and subpatent infections, and also identifies the causative spe-
cies [26]. It can be used for microscopy or RDT confirmation and may be the only safe choice
for low parasitemia detection and for finding asymptomatic infections in non-endemic settings
[27], however it could be considered rather expensive.
Both in endemic and non-endemic areas, RDTs are increasingly being used as a malaria di-
agnostic tool [28, 29]. The main advantages are that it is a simple and cheap method, it does
not require special equipment or intensive training, it is a very quick method providing results
in only 15–30 minutes and its interpretation is more objective than that of light microscopy
[30]. RDTs can diagnose malaria in settings where the distance from effective microscopy ser-
vices is an inevitable fact [30] and also during disease surveillance or outbreak investigations
[31]. On the other hand, it is not a qualitative method as it cannot measure the parasitemia lev-
els and thus the infection severity and may not be able to detect very low parasitemias/asymp-
tomatic infections [30]. We chose the SD Bioline Malaria Ag P.f./Pan 05FK60 test, as it was
proved to be one of the best performers in the WHO/TDR/FIND/CDC evaluation programme
[32], despite one of its shortcomings was that it cannot differentiate specifically for P. vivax. It
has been suggested that due to its drawbacks, the RDT could not be probably established as the
unique diagnostic method in non-endemic areas, where conventional microscopic examination
is required to confirm the diagnosis, as the RDT may not detect a low parasitemia infection
[33], in comparison to microscopy which is able to detect lower levels of parasitemia than
RDT. The majority of RDT tests show high level of plasmodium detection at parasitemia of at
least 2000 parasites/μL [34]. Similar detection limit was identified in our study, as the level of
parasitemia of light microscopy positive and PCR negative sample was estimated at 0.04%
(~500 parasites/μL). Only a few studies concerning RDT evaluation have taken place in non-
endemic settings, where, in addition, only a small number of RDTs was used [8]. Even though
previous evaluations support that the microscopy cannot be surpassed by RDT use, our results
indicate that RDTs perform equally and sometimes even better when compared to convention-
al microscopy and can be used in control activities decreasing the time between diagnosis
and treatment.
Our study has some limitations which should be taken into account. The main limitation of
our study is the small number of 45 PCR positive samples which affected the confidence inter-
val (C.I.) of the RDT sensitivity assessment, while the C.I. of the specificity assessment was nar-
rower due to higher number of samples. Moreover, this study was not a clinical trial (Phase III)
but a descriptive observational study and as such has the limitations and the biases (possible se-
lection bias) of an observational study. Thus, the results could not be directly compared to
those of trials which evaluated the performance of RDTs [35,36,37].
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In conclusion, our field study suggested that the RDT used for malaria diagnosis in a non-
endemic area demonstrated satisfactory agreement with traditional tools of malaria diagnosis
(light microscopy, PCR).
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